Eligibility Diabetes NCT00655200

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00655200
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients diagnosed with type 1 or type 2 diabetes mellitus.
Descrizione

Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Non-Insulin-Dependent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2]
C0011860
newly diagnosed insulin naive patients
Descrizione

Insulin naive

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0919936
patients currently on human insulin or on basal insulin
Descrizione

Insulin, Human | Basal insulin

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0795635
UMLS CUI [2]
C0650607
patients prescribed with levemir™ flexpen™ (insulin detemir) therapy
Descrizione

Levemir | Insulin detemir

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1314782
UMLS CUI [2]
C0537270
usage should be in accordance with the current prescribing information (see attached prescribing information)
Descrizione

Adherence Prescription information

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1510802
UMLS CUI [1,2]
C1546473
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous history of hypersensitivity to insulin detemir (levemir™) and its excipients (see attached prescribing information)
Descrizione

Hypersensitivity Insulin detemir | Hypersensitivity Levemir | Hypersensitivity Insulin detemir Excipient | Hypersensitivity Levemir Excipient

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0537270
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C1314782
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0537270
UMLS CUI [3,3]
C0015237
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C1314782
UMLS CUI [4,3]
C0015237
contraindications and warnings specified in the current prescribing information (see attached prescribing information)
Descrizione

Medical contraindication Prescription information | Warning Prescription information

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C1546473
UMLS CUI [2,1]
C0871599
UMLS CUI [2,2]
C1546473
pregnant women, those planning to become pregnant, or women who are breastfeeding
Descrizione

Pregnancy | Pregnancy, Planned | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032992
UMLS CUI [3]
C0006147
patients who are already on human premix or premix analogue (unless they are going to be shifted to basal-bolus therapy)
Descrizione

Other Coding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3846158
children below 6 years old
Descrizione

Children | Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0008059
UMLS CUI [2]
C0001779

Similar models

Eligibility Diabetes NCT00655200

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00655200
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Non-Insulin-Dependent
Item
patients diagnosed with type 1 or type 2 diabetes mellitus.
boolean
C0011854 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
Insulin naive
Item
newly diagnosed insulin naive patients
boolean
C0021641 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
Insulin, Human | Basal insulin
Item
patients currently on human insulin or on basal insulin
boolean
C0795635 (UMLS CUI [1])
C0650607 (UMLS CUI [2])
Levemir | Insulin detemir
Item
patients prescribed with levemir™ flexpen™ (insulin detemir) therapy
boolean
C1314782 (UMLS CUI [1])
C0537270 (UMLS CUI [2])
Adherence Prescription information
Item
usage should be in accordance with the current prescribing information (see attached prescribing information)
boolean
C1510802 (UMLS CUI [1,1])
C1546473 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Hypersensitivity Insulin detemir | Hypersensitivity Levemir | Hypersensitivity Insulin detemir Excipient | Hypersensitivity Levemir Excipient
Item
previous history of hypersensitivity to insulin detemir (levemir™) and its excipients (see attached prescribing information)
boolean
C0020517 (UMLS CUI [1,1])
C0537270 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1314782 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0537270 (UMLS CUI [3,2])
C0015237 (UMLS CUI [3,3])
C0020517 (UMLS CUI [4,1])
C1314782 (UMLS CUI [4,2])
C0015237 (UMLS CUI [4,3])
Medical contraindication Prescription information | Warning Prescription information
Item
contraindications and warnings specified in the current prescribing information (see attached prescribing information)
boolean
C1301624 (UMLS CUI [1,1])
C1546473 (UMLS CUI [1,2])
C0871599 (UMLS CUI [2,1])
C1546473 (UMLS CUI [2,2])
Pregnancy | Pregnancy, Planned | Breast Feeding
Item
pregnant women, those planning to become pregnant, or women who are breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Other Coding
Item
patients who are already on human premix or premix analogue (unless they are going to be shifted to basal-bolus therapy)
boolean
C3846158 (UMLS CUI [1])
Children | Age
Item
children below 6 years old
boolean
C0008059 (UMLS CUI [1])
C0001779 (UMLS CUI [2])